Herpes Simplex Infections
Gilead’s $35M Herpes Deal with Assembly Biosciences and Recent FDA Approvals
Gilead; Assembly Biosciences; herpes; HSV; ABI-1179; ABI-5366; FDA; Boehringer; Roche
GSK’s Therapeutic Herpes Vaccine Fails to Meet Efficacy Objective in Phase I/II Trial
GSK, therapeutic herpes vaccine, herpes simplex virus, HSV, vaccine failure, clinical trial